首页> 外文期刊>応用薬理 >Spinal Muscarinic Recptor Subtypes Regulating Voiding In Rats
【24h】

Spinal Muscarinic Recptor Subtypes Regulating Voiding In Rats

机译:调节大鼠脊髓空洞的毒蕈碱受体亚型

获取原文
获取原文并翻译 | 示例
           

摘要

Muscarinic receptors in the central nervous system are involved in the control of voiding function. As the muscarinic receptor subtypes involved in the function of the spinal micturition reflex pathway have not yet been determined, we examined the effects of intrathecal (i.t.) administration of muscarinic Ml to M4 receptor subtype antagonists on voiding function in rats. An intrathecal administration cannula and a bladder cannula were inserted into female Sprague-Dawley rats under halothane anesthesia, and cystometry was performed in conscious animals. Bladder capacity, maximal voiding pressure (MVP), and post-void residual volume were measured, and voiding efficiency (VE) was calculated based on these values. Pirenzepine, methoctramine, p-fluorohexahydro-sila-difenidol, and tropicamide were used as Ml,M2, M3, and M4 muscarinic receptor antagonists, respectively. Although voiding parameters were not altered by 30 mug of the respective muscarinic receptor subtype antagonists, atropine at 10 mug and 30mug reduced MVP and VE. Combined administration of M2 and M4 or M2 and Ml muscarinic receptor antagonists at 30 mug reduced the VE and MVP or the VE, respectively, and that of the other two muscarinic receptor antagonists at 30|xg did not alter the micturition parameters. Combined administration of M2 and M4 or M2 and Ml muscarinic receptor antagonists arrested bladder contraction in other rats. The muscarinic receptors in the lumbosarcral micturition center are involved in facilitatory function in the voiding mechanism, but their involvement of the cholinergic system is only in part in the voiding function.
机译:中枢神经系统中的毒蕈碱受体参与排尿功能的控制。由于尚未确定涉及排尿排尿反射通路功能的毒蕈碱受体亚型,因此我们研究了鞘内(i.t.)将毒蕈碱M1给予M4受体亚型拮抗剂对大鼠排尿功能的影响。在氟烷麻醉下,将鞘内注射套管和膀胱套管插入雌性Sprague-Dawley大鼠中,并在有意识的动物中进行膀胱测压。测量膀胱容量,最大排尿压力(MVP)和排尿后残留量,并基于这些值计算排尿效率(VE)。哌仑西平,甲基辛特拉明,对氟六氢-西拉非尼多和托吡酰胺分别用作M1,M2,M3和M4毒蕈碱受体拮抗剂。尽管30杯相应的毒蕈碱受体亚型拮抗剂不会改变排尿参数,但10杯和30杯的阿托品会降低MVP和VE。在30杯下联合施用M2和M4或M2和M1毒蕈碱受体拮抗剂分别降低了VE和MVP或VE,并且在30μg下另外两种毒蕈碱受体拮抗剂的施用不改变排尿参数。 M2和M4或M2和M1毒蕈碱受体拮抗剂的联合施用阻止了其他大鼠的膀胱收缩。腰sar排尿中心的毒蕈碱受体参与排尿机制中的促进功能,但它们参与胆碱能系统仅部分参与排尿功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号